Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma
2011

GUT-70's Effects on Mantle Cell Lymphoma

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jin L, Tabe Y, Kimura S, Zhou Y, Kuroda J, Asou H, Inaba T, Konopleva M, Andreeff M, Miida T

Primary Institution: Juntendo University School of Medicine

Hypothesis

Does GUT-70 have antiproliferative effects on mantle cell lymphoma (MCL) cells through Hsp90 inhibition?

Conclusion

GUT-70 has significant antiproliferative effects in MCL cells with mutant p53 by inhibiting Hsp90.

Supporting Evidence

  • GUT-70 reduced cell proliferation and increased apoptosis in MCL cells.
  • GUT-70 showed greater efficacy in cells with mutant p53.
  • GUT-70 induced degradation of Hsp90 client proteins.
  • Combination treatment with GUT-70 and bortezomib showed synergistic effects.
  • GUT-70 upregulated Noxa and activated BAK in MCL cells.

Takeaway

GUT-70 is a new medicine that helps stop cancer cells from growing and can make them die, especially in a type of cancer called mantle cell lymphoma.

Methodology

MCL cell lines were treated with GUT-70, and effects on cell proliferation, apoptosis, and protein expression were analyzed.

Potential Biases

Potential bias in cell line selection and treatment conditions.

Limitations

The study primarily focuses on in vitro results, and further in vivo studies are needed.

Participant Demographics

Four MCL cell lines with different p53 statuses were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606007

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication